Natural Beauty Bio-Technology Limited (0157.HK)
HKD 0.48
(-2.06%)
HKD 0.48
(-2.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 16.21 Million | 8.32 Million | 42.78 Million | 30.08 Million | 20.31 Million | 73.98 Million |
| Net Income | -15.11 Million | -30.47 Million | 35.26 Million | 7.75 Million | 21.9 Million | 26.25 Million |
| Depreciation & Amortization | 26.65 Million | 34.29 Million | 34.95 Million | 37.26 Million | 30.9 Million | 24.36 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 4.4 Million | -120 Thousand | -35.82 Million | -28.09 Million | -45 Million | 19.73 Million |
| Other non-cash items | 270 Thousand | 4.61 Million | 8.39 Million | 13.16 Million | 12.51 Million | 3.63 Million |
| Investing Cash Flow | -69.11 Million | -43.98 Million | -31.2 Million | -50.62 Million | -63.74 Million | -61.15 Million |
| Investments in PPE | -69.11 Million | -44.3 Million | -38.11 Million | -73.86 Million | -76.41 Million | -51.82 Million |
| Acquisitions | 1000.00 | 329 Thousand | 8.15 Million | 20.07 Million | - | -18.92 Million |
| Investment purchases | - | - | -1.25 Million | -24.97 Million | - | - |
| Sales/Maturities of investments | - | - | -8.95 Million | 3.16 Million | 12.66 Million | - |
| Other Investing Activities | 1.5 Million | 3.55 Million | 8.95 Million | 24.97 Million | 3.54 Million | 9.59 Million |
| Financing Cash Flow | 49.64 Million | 18.09 Million | 14.3 Million | 29.85 Million | 20.19 Million | -96.1 Million |
| Debt repayment | -54.34 Million | -31.16 Million | -27.24 Million | -38.77 Million | -24.91 Million | - |
| Dividends payments | - | -6 Million | -6 Million | - | - | -96.1 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 103.99 Million | 55.26 Million | 47.56 Million | 68.62 Million | 45.1 Million | - |
| Accounts receivables | 1.01 Million | 19.71 Million | 6.74 Million | 337 Thousand | -42.67 Million | 24.98 Million |
| Accounts payables | -16.09 Million | -23.25 Million | -16.55 Million | 12.7 Million | 10.36 Million | -11.68 Million |
| Inventory | 16.5 Million | -1.01 Million | -27.03 Million | -24.66 Million | -17.65 Million | -5.25 Million |
| Other working capital | 2.97 Million | 4.43 Million | 1.01 Million | -16.47 Million | 4.96 Million | 11.68 Million |
| Cash at beginning of period | 160.59 Million | 188.21 Million | 158.15 Million | 138.97 Million | 184.5 Million | 288.9 Million |
| Cash at end of period | 158.74 Million | 160.59 Million | 188.21 Million | 158.15 Million | 138.97 Million | 158.21 Million |
| Capital Expenditure | -69.11 Million | -44.3 Million | -38.11 Million | -73.86 Million | -76.41 Million | -51.82 Million |
| Effect of forex changes on cash | 1.4 Million | -9.87 Million | 4.06 Million | 9.65 Million | -2.96 Million | -18.03 Million |
| Net cash flow / Change in cash | -1.84 Million | -27.61 Million | 30.06 Million | 19.17 Million | -45.53 Million | -130.68 Million |
| Free Cash Flow | -52.9 Million | -35.98 Million | 4.66 Million | -43.77 Million | -56.09 Million | 22.15 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -30.45 Million | -5.7 Million | -15.11 Million | -9.4 Million | -30.47 Million | -223 Thousand |
| Depreciation & Amortization | 13.38 Million | 12.27 Million | 26.65 Million | 14.38 Million | 34.29 Million | 17.16 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 17.26 Million | 4.4 Million | - | -120 Thousand | 18.71 Million |
| Other non-cash items | -9.46 Million | 15.58 Million | 270 Thousand | 42.38 Million | 4.61 Million | 18.43 Million |
| Investing Cash Flow | -16.78 Million | 1.74 Million | -69.11 Million | -70.85 Million | -43.98 Million | -42.43 Million |
| Investments in PPE | -22.3 Million | -28.35 Million | -69.11 Million | -40.75 Million | -44.3 Million | -32.93 Million |
| Acquisitions | 119 Thousand | -34.76 Million | 1000.00 | 1000.00 | 329 Thousand | 329 Thousand |
| Investment purchases | - | 34.76 Million | - | -34.76 Million | - | 5.54 Million |
| Sales/Maturities of investments | 4.86 Million | -4.66 Million | - | 4.66 Million | - | -9.82 Million |
| Other Investing Activities | 5.52 Million | 30.69 Million | 1.5 Million | -29.18 Million | 3.55 Million | -5.54 Million |
| Financing Cash Flow | -11.58 Million | 1.4 Million | 49.64 Million | 48.24 Million | 18.09 Million | 15.97 Million |
| Debt repayment | -7.66 Million | -3.43 Million | -54.34 Million | -50.9 Million | -31.16 Million | -25.23 Million |
| Dividends payments | - | - | - | - | -6 Million | -6 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3.91 Million | -2.09 Million | 103.99 Million | -3.52 Million | 55.26 Million | 19.77 Million |
| Accounts receivables | - | 1.01 Million | 1.01 Million | - | 19.71 Million | 19.71 Million |
| Accounts payables | - | - | -16.09 Million | - | -23.25 Million | - |
| Inventory | - | 16.5 Million | 16.5 Million | - | -1.01 Million | -1.01 Million |
| Other working capital | - | -262 Thousand | 2.97 Million | - | 4.43 Million | 14 Thousand |
| Cash at beginning of period | 158.74 Million | 157.05 Million | 160.59 Million | 160.59 Million | 188.21 Million | 183.75 Million |
| Cash at end of period | 95.5 Million | 158.74 Million | 158.74 Million | 157.05 Million | 160.59 Million | 160.59 Million |
| Capital Expenditure | -22.3 Million | -28.35 Million | -69.11 Million | -40.75 Million | -44.3 Million | -32.93 Million |
| Effect of forex changes on cash | -8.34 Million | 6.59 Million | 1.4 Million | -5.18 Million | -9.87 Million | 1.07 Million |
| Net cash flow / Change in cash | -63.23 Million | 1.69 Million | -1.84 Million | -3.54 Million | -27.61 Million | -23.16 Million |
| Free Cash Flow | -48.83 Million | -30.74 Million | -52.9 Million | -22.15 Million | -35.98 Million | -31.89 Million |
SOI
YRLLF
7981
DBG
9104
MIXIF